Key chemokines direct migration of immune cells in solid tumors

K Kohli, VG Pillarisetty, TS Kim - Cancer gene therapy, 2022 - nature.com
Immune cell infiltration into solid tumors, their movement within the tumor microenvironment
(TME), and interaction with other immune cells are controlled by their directed migration …

International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - ASPET
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

Kidney transplantation in children

VR Dharnidharka, P Fiorina… - New England Journal of …, 2014 - Mass Medical Soc
Kidney Transplantation in Children | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

[HTML][HTML] International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - ncbi.nlm.nih.gov
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

M Ben Nasr, S Tezza, F D'Addio, C Mameli… - Science translational …, 2017 - science.org
Immunologically based clinical trials performed thus far have failed to cure type 1 diabetes
(T1D), in part because these approaches were nonspecific. Because the disease is driven …

Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis

A El-Badawy, N El-Badri - PloS one, 2016 - journals.plos.org
Background Stem cell therapy is a promising therapeutic modality for advanced diabetes
mellitus (DM). This study presents a meta-analysis of relevant clinical trials to determine the …

Diabetes impairs stem cell and proangiogenic cell mobilization in humans

GP Fadini, M Albiero, S Vigili de Kreutzenberg… - Diabetes …, 2013 - Am Diabetes Assoc
OBJECTIVE Diabetes mellitus (DM) increases cardiovascular risk, at least in part, through
shortage of vascular regenerative cells derived from the bone marrow (BM). In experimental …

Advances in bone marrow stem cell therapy for retinal dysfunction

SS Park, E Moisseiev, G Bauer, JD Anderson… - Progress in retinal and …, 2017 - Elsevier
The most common cause of untreatable vision loss is dysfunction of the retina. Conditions,
such as age-related macular degeneration, diabetic retinopathy and glaucoma remain …

Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis

F D'Addio, A Valderrama Vasquez, M Ben Nasr… - Diabetes, 2014 - Am Diabetes Assoc
Type 1 diabetes (T1D) is one of the major autoimmune diseases affecting children and
young adults worldwide. To date, the different immunotherapies tested have achieved …

Concise review: perspectives and clinical implications of bone marrow and circulating stem cell defects in diabetes

GP Fadini, S Ciciliot, M Albiero - Stem Cells, 2017 - academic.oup.com
Diabetes mellitus is a complex systemic disease characterized by severe morbidity and
excess mortality. The burden of its multiorgan complications relies on an imbalance between …